Evidence map›Paper›PMID 19918242›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2010

Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Youli Wang, Kathleen O Heilig, Andrew W Minto, Shenglin Chen, Minghui Xiang, David A Dean, Richard C Geiger, Anthony Chang, Dimitrina D Pravtcheva, Martin Schlimme and 3 more

Open access · greenAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Youli WangDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Kathleen O Heilig
Andrew W Minto
Shenglin Chen
Minghui Xiang
David A Dean
Richard C Geiger
Anthony Chang
Dimitrina D Pravtcheva
Martin Schlimme
Dilip K Deb
Ying Wang
Charles W Heilig
University of Chicago · USJohns Hopkins Medicine · USNorthwestern University · USJohns Hopkins University · USNew York State Office for People With Developmental Disabilities · US

Funding

Cytoplasmic trafficking of non-viral gene therapy vectorsR01EB009903 · NIBIB · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2009 to 2017
$2.7M
NIBIB NIH HHS R01 EB009903
6 · The paper itself

Abstract

Reduced nephron numbers may predispose to renal failure. We hypothesized that glucose transporters (GLUTs) may contribute to progression of the renal disease, as GLUTs have been implicated in diabetic glomerulosclerosis and hypertensive renal disease with mesangial cell (MC) stretch. The Os (oligosyndactyly) allele that typically reduces nephron number by approximately 50%, was repeatedly backcrossed from ROP (Ra/+ (ragged), Os/+ (oligosyndactyly), and Pt/+ (pintail)) Os/+ mice more than six times into the Fvb mouse background to obtain Os/+ and +/+ mice with the Fvb background for study. Glomerular function, GLUT1, signaling, albumin excretion, and structural and ultrastructural changes were assessed. The FvbROP Os/+ mice (Fvb background) exhibited increased glomerular GLUT1, glucose uptake, VEGF, glomerular hypertrophy, hyperfiltration, extensive podocyte foot process effacement, marked albuminuria, severe extracellular matrix (ECM) protein deposition, and rapidly progressive renal failure leading to their early demise. Glomerular GLUT1 was increased 2.7-fold in the FvbROP Os/+ mice vs controls at 4 weeks of age, and glucose uptake was increased 2.7-fold. These changes were associated with the activation of glomerular PKCbeta1 and NF-kappaB p50 which contribute to ECM accumulation. The cyclic mechanical stretch of MCs in vitro, used as a model for increased MC stretch in vivo, reproduced increased GLUT1 at 48 h, a stimulus for increased VEGF expression which followed at 72 h. VEGF was also shown to act in a positive feedback manner on MC GLUT1, increasing GLUT1 expression, glucose uptake and fibronectin (FN) accumulation in vitro, whereas antisense suppression of GLUT1 largely blocked FN upregulation by VEGF. The FvbROP Os/+ mice exhibited an early increase in glomerular GLUT1 leading to increased glomerular glucose uptake PKCbeta1, and NF-kappaB activation, with excess ECM accumulation. A GLUT1-VEGF-GLUT1 positive feedback loop may play a key role in contributing to renal disease in this model of nondiabetic glomerulosclerosis.

Indexed as

AlbuminuriaAllelesAnimalsCells, CulturedCreatinineDisease ProgressionExtracellular Matrix ProteinsGlomerular MesangiumGlucose Transporter Type 1ImmunohistochemistryIsoenzymesKidneyKidney GlomerulusMiceMice, Inbred C57BLMice, Mutant StrainsCreatinineExtracellular Matrix ProteinsGlucose Transporter Type 1IsoenzymesNF-kappa BProtein Kinase CSlc2a1 protein, mouseTransforming Growth Factor beta1Vascular Endothelial Growth Factor Avascular endothelial growth factor A, mouse

Identifiers

PMID19918242
PMCPMC4150870
OpenAlexW1975261370

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.